MBX Biosciences (MBX) Interest & Investment Income (2023 - 2026)
MBX Biosciences (MBX) reported Interest & Investment Income of $3.7 million for Q1 2026, up 41.49% on a YoY basis from $2.6 million in Q1 2025, and down 65.88% sequentially from $11.0 million in Q4 2025.
MBX Biosciences (MBX) Interest & Investment Income (2023 - 2026) Analysis & Trends
MBX Biosciences (MBX) has 4 years of Interest & Investment Income data on file, last reported at $3.7 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 41.49% year-over-year to $3.7 million; the trailing twelve-month figure through Mar 2026 stood at $14.8 million (up 65.12% YoY), and the FY2025 full-year result was $11.1 million, up 76.72% from the prior year.
- Interest & Investment Income retreated to $3.7 million in Q1 2026, from $11.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $11.0 million in Q4 2025 to a low of -$63000.0 in Q1 2024.
- A 4-year average of $2.2 million and a median of $121000.0 in 2024 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income soared 11429.63% in 2024 and tumbled 250.0% in 2025, its largest moves.
- Tracing MBX's Interest & Investment Income over 4 years: stood at $54000.0 in 2023, then jumped by 11429.63% to $6.2 million in 2024, then soared by 76.44% to $11.0 million in 2025, then slumped by 65.88% to $3.7 million in 2026.
- Business Quant data shows MBX's Interest & Investment Income at $3.7 million in Q1 2026, $11.0 million in Q4 2025, and $143000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | MBX Biosciences | 2.85 Bn | 2.85 Bn | - | 3.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.75 Mn |
| Dec 31, 2025 | 10.99 Mn |
| Sep 30, 2025 | 143,000.00 |
| Jun 30, 2025 | -42,000.00 |
| Mar 31, 2025 | 2.65 Mn |
| Dec 31, 2024 | 6.23 Mn |
| Sep 30, 2024 | 121,000.00 |
| Jun 30, 2024 | -12,000.00 |
| Mar 31, 2024 | -63,000.00 |
| Dec 31, 2023 | 54,000.00 |
| Sep 30, 2023 | 9,000.00 |